These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18078390)

  • 1. Lessons from oncology to understand and treat pulmonary hypertension.
    Adnot S; Eddahibi S
    Int J Clin Pract Suppl; 2007 Dec; (158):19-25. PubMed ID: 18078390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
    Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S
    Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
    Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
    Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotonin pathway in pulmonary hypertension.
    Eddahibi S; Adnot S
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):621-5. PubMed ID: 16878724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.
    Sakao S; Tatsumi K
    Int J Cardiol; 2011 Feb; 147(1):4-12. PubMed ID: 20692712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary cellular proliferation and its control during development of pulmonary hypertension].
    Cai YN
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):298-302. PubMed ID: 1302362
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Smooth muscle cells and atherogenesis].
    Larrue J; Desgranges C
    Arch Mal Coeur Vaiss; 1987 Sep; 80 Spec No():31-6. PubMed ID: 3118847
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of pulmonary hypertension.
    Yildiz P
    Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in autoimmune rheumatic diseases.
    Carreira PE
    Autoimmun Rev; 2004 Jun; 3(4):313-20. PubMed ID: 15246028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of pulmonary arterial hypertension: lessons from cancer.
    Guignabert C; Tu L; Le Hiress M; Ricard N; Sattler C; Seferian A; Huertas A; Humbert M; Montani D
    Eur Respir Rev; 2013 Dec; 22(130):543-51. PubMed ID: 24293470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension.
    Happé CM; Szulcek R; Voelkel NF; Bogaard HJ
    Vascul Pharmacol; 2016 Aug; 83():17-25. PubMed ID: 26804008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin causes pulmonary hypertension by upregulating smooth muscle endothelin type-B receptors: role of aldose reductase.
    Dschietzig T; Alexiou K; Richter C; Bobzin M; Baumann G; Stangl K; Brunner F
    Shock; 2008 Aug; 30(2):189-96. PubMed ID: 18091567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastase and the pathobiology of unexplained pulmonary hypertension.
    Rabinovitch M
    Chest; 1998 Sep; 114(3 Suppl):213S-224S. PubMed ID: 9741572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular interplay in pulmonary arterial hypertension: implications for new therapies.
    Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T
    Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling.
    Wojciak-Stothard B
    Postgrad Med J; 2008 Jul; 84(993):348-53. PubMed ID: 18716013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary vascular remodeling in congenital cardiovascular abnormalities: an eternal topic].
    Liu HM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):805-9. PubMed ID: 24131828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.
    Smadja DM; Gaussem P; Mauge L; Israël-Biet D; Dignat-George F; Peyrard S; Agnoletti G; Vouhé PR; Bonnet D; Lévy M
    Circulation; 2009 Jan; 119(3):374-81. PubMed ID: 19139384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dana Point: what is new in the treatment of pulmonary hypertension?].
    Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.